STAAR Surgical Company (NASDAQ:STAA) Files An 8-K Other Events
Item 8.01 Other Events.
On May 11, 2017, STAAR Surgical Company (the Company) published a
press release reporting CE Mark approval for the EVO Visian ICL
with an aspheric (EDOF) optic, a copy of which is furnished as
Exhibit 99.1 to this report and is incorporated herein by this
reference.
This information and the information contained in the press
release shall not be deemed filed for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section. The information in
Item 2.02 of this Current Report, and Exhibit 99.1 are not
incorporated by reference into any filings of STAAR made under
the Securities Act of 1933, as amended, whether made before or
after the date of this Current Report, regardless of any general
incorporation language in the filing unless specifically stated
so therein.
Item 9.01 Financial Statements and Exhibits
| Exhibit No. | Description | |
| 99.1 | Press release of the Company dated May 11, 2017 | |
About STAAR Surgical Company (NASDAQ:STAA)
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). It sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world. STAAR Surgical Company (NASDAQ:STAA) Recent Trading Information
STAAR Surgical Company (NASDAQ:STAA) closed its last trading session down -0.15 at 9.50 with 63,945 shares trading hands.
